beluuga.ai
JA
Try the Live Demo →
Overview
Retail Trade

COSMOS CHOUZAI Pharmacy Co.,Ltd.

COSMOS CHOUZAI Pharmacy operates a network of approximately 53 dispensing pharmacies primarily in Aichi Prefecture (Nagoya and surrounding areas) and parts of Gifu Prefecture, providing prescription dispensing services, home pharmacy care, and health consultation including nutritionist support. The company differentiates itself by going beyond standard prescription dispensing to offer self-medication guidance and deeper patient engagement, acting as a bridge between patients and clinics. Its group companies cover generic drug wholesaling (Meisai Yakuhin), pharmacist exam preparation (PharmaProduct), and additional pharmacy operations.

Market Cap
¥—B
EV
¥—B
Stock¥700
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
—
LTM EV/EBIT
—
LTM PER
—
LTM PBR
—
No price data
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
6.19US$39.5M'24/36.29US$40.1M'25/36.51US$41.5M'26/3
Net Income 5Y (¥B)
0.03US$0.17M'24/30.14US$0.88M'25/30.18US$1.12M'26/3
Shareholders
Top 10 hold 100.0%
as of 2026-03-31 · Source: Annual Securities Report
1
Meihoku Co., Ltd.
99.99%
Management
4 officers
Hironori MATSUURA
Representative Director, President
Apr. 1996: Joined Hack Kimisaw Co., Ltd. / May 1996: Registered as pharmacist / Apr. 1997: Joined Fujishima Dispensing Pharmacy Co., Ltd. / Dec. 1999: Founded the Company (Chuo Chozai Co., Ltd., limited liability company) / Sep. 2002: Converted to Meihoku Chozai Co., Ltd.; appointed Representative Director & President (current) / May 2007: Appointed Director, Medical Co., Ltd. / Jun. 2008: Appointed Director, Tsubasa Co., Ltd. (now Apo Agent Co., Ltd.) (current) / Jan. 2012: Appointed Director, Meinichi Yakuhin Co., Ltd. / May 2020: Appointed Representative Director, Meinichi Yakuhin Co., Ltd. (current) / Nov. 2021: Appointed Representative Director, Pharma Product Co., Ltd. (current) / Dec. 2021: Appointed Representative Director, Koyo Yakkyoku Co., Ltd. (current) / Mar. 2023: Appointed Representative Director, Medical Co., Ltd. / Oct. 2024: Appointed Representative Director, Taizen Co., Ltd. (limited liability company) (current) / Apr. 2025: Resigned as Representative Director, Medical Co., Ltd. (due to merger)
1972-09-27
Takahiro ICHIHARA
Director, Head of Academic & Pharmaceutical Education Division
Apr. 2000: Joined Sankyo Co., Ltd. / Jun. 2000: Registered as pharmacist / Jul. 2007: Joined the Company / Jun. 2023: Appointed Director of the Company (current) / Jan. 2026: Appointed Director, Pharma Product Co., Ltd. (current)
1977-10-23
Chiho TAKATO
Director, Head of Welfare Business Division
Oct. 1997: Joined Aichi Medical Service Center Co., Ltd. / Sep. 2002: Joined Aisei Pharmacy Co., Ltd. / Jan. 2015: Joined Mikanyama Orthopedic Surgery Medical Corporation / Feb. 2020: Joined the Company / Jun. 2025: Appointed Director of the Company (current) / Jan. 2026: Appointed Director, Pharma Product Co., Ltd. (current)
1970-09-25
Haruhiko IKEDA
Audit & Supervisory Board Member
Dec. 2008: Joined KPMG AZSA LLC (formerly Azsa & Co.) / Jan. 2013: Registered as Certified Public Accountant / Oct. 2019: Established Nakayamate Accounting Office (current) / Dec. 2019: Registered as Tax Accountant / Jun. 2023: Appointed Audit & Supervisory Board Member of the Company (current) / Jun. 2024: Appointed Managing Member, Shingetsu LLC (current) / Nov. 2025: Appointed Outside Audit & Supervisory Board Member, Liart Co., Ltd. (current)
1978-05-15
Large Shareholding Reports
No filings
Disclosures
No disclosures
Primary Source Filings
TDnet
2026-06-26
発行者情報
FY ending Mar 2026
View PDF →
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →